Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | Director | December 07, 2012 | December 07, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date December 07, 2012 · Filed December 07, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stock, $0.01 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
Holding disclosure · report date 2012-12-07 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 0 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ABBOTT LABORATORIES
Report date February 28, 2013 · Filed March 02, 2013
Section 16 reporting ended · disclosed 2013-03-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 137,475 |
Reported balance
After 2013-02-28 transaction · row 1
1 source rowRow 1 · 2013-02-28 · Tax withholding · Disposed 9,188 · Balance 137,475 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 4,134 |
Reported balance
Holding disclosure · report date 2013-02-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 4,134 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2013. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 27, 2013.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 2,612 | $41.38 | $108,084.56 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,780 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2007 Filed Feb 1, 2007 01:33 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,778 | $49.63 | $336,398.24 |
DisclosureSEC source: 0001104659-07-006235 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,168 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2006 Filed Oct 17, 2006 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 1,704 | $46.72 | $79,610.88 |
DisclosureSEC source: 0001104659-06-067062 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,390 Read SEC document |
| August 21, 2006 Filed Sep 14, 2006 18:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 65 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-061117 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,094 Read SEC document |
| February 21, 2006 Filed Feb 22, 2006 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 174 | $43.80 | $7,621.20 |
DisclosureSEC source: 0001104659-06-011231 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,159 Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 511 | $44.15 | $22,560.65 |
DisclosureSEC source: 0001104659-06-011231 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,833 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 36,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011231 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: common shares · 36,000 shares Expires 2016-02-16 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 12,000 on 2/17/2007, 12,000 on 2/17/2008 and 12,000 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 22:51 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 12,500 | $44.16 | $552,000.00 |
DisclosureSEC source: 0001104659-06-011231 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,333 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 12,431 | $0.00 Strike: $42.83 | $0.00 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,431 Underlying: common shares · 12,431 shares Expires 2013-02-13 F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 14,685 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,050 Underlying: common shares · 14,685 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 323 | $43.73 | $14,124.79 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,344 Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 12,431 | $42.83 | $532,419.73 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,667 Read SEC document |
| February 14, 2006 Filed Feb 16, 2006 23:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 14,685 | $33.23 | $488,003.11 |
DisclosureSEC source: 0001104659-06-010251 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 2,988 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-06-005419 · a4.xml · derivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,988 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 2,916 | $43.00 | $125,388.00 |
DisclosureSEC source: 0001104659-06-005419 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,413 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 2,988 | $41.38 | $123,643.44 |
DisclosureSEC source: 0001104659-06-005419 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,329 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2005 Filed Apr 14, 2005 18:32 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-016449 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,341 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 15,473 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,473 Underlying: common shares · 15,473 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 18,736 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,735 Underlying: common shares · 18,736 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,661 | $0.00 Strike: $18.39 | $0.00 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 6,661 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 18,099 | $46.65 | $844,318.35 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,441 Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 18,736 | $33.23 | $622,623.51 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:47 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 6,661 | $18.39 | $122,508.45 |
DisclosureSEC source: 0001104659-05-010426 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,804 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 34,800 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008020 · a4.xml · derivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,800 Underlying: common shares · 34,800 shares Expires 2015-02-17 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 11,600 on 2/18/06, 11,600 on 2/18/07 and 11,600 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 5,200 | $46.34 | $240,968.00 |
DisclosureSEC source: 0001104659-05-008020 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,143 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| October 21, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon Shares without par value | 120 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,943 Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,612 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 11 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,612 Underlying: Common Shares · 2,612 shares Expires 2007-02-13 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,988 | $0.00 Strike: $41.38 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 10 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,988 Underlying: Common Shares · 2,988 shares Expires 2006-02-08 F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,941 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 9 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 3,941 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 6,022 | $0.00 Strike: $20.53 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 8 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 6,022 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock options granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,000 | $0.00 Strike: $18.39 | $0.00 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,661 Underlying: Common Shares · 1,000 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock options granted pursuant to the Abbott Laboratories 1991 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon Shares without par value | 6,044 | $41.38 | $250,100.72 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,063 Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 3,941 | $27.43 | $108,112.66 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,107 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 6,022 | $20.53 | $123,659.96 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 20, 2004 Filed Oct 22, 2004 16:58 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon Shares without par value | 1,000 | $18.39 | $18,391.90 |
DisclosureSEC source: 0001104659-04-031506 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2004 Filed Jun 3, 2004 15:56 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,353 | $41.00 | $137,473.00 |
DisclosureSEC source: 0001104659-04-016080 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,144 Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 25,000 | $0.00 Strike: $43.66 | $0.00 |
DisclosureSEC source: 0001104659-04-005603 · a4.xml · derivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: common shares · 25,000 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 8,334 on 2/20/05, 8,333 on 2/20/06 and 8,333 on 2/20/07. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 3,500 | $43.66 | $152,810.00 |
DisclosureSEC source: 0001104659-04-005603 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,497 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 13,875 | $0.00 Strike: $44.31 | $0.00 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · derivative · entry 7 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,875 Underlying: Common shares · 13,875 shares Expires 2013-02-13 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 15,724 | $0.00 Strike: $35.36 | $0.00 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · derivative · entry 6 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,276 Underlying: Common shares · 15,724 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,960 | $0.00 Strike: $14.32 | $0.00 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,960 shares Expires 2004-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 14,508 | $44.31 | $642,849.48 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · nonDerivative · entry 3 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,997 Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 15,724 | $35.36 | $556,000.64 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2004 Filed Feb 19, 2004 20:28 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,960 | $14.32 | $28,067.20 |
DisclosureSEC source: 0001104659-04-005168 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,781 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2003 Filed Nov 18, 2003 21:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 20,777 | $0.00 Strike: $43.86 | $0.00 |
DisclosureSEC source: 0001104659-03-026965 · a4.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,777 Underlying: Common shares · 20,777 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| November 14, 2003 Filed Nov 18, 2003 21:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 23,785 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-03-026965 · a4.xml · derivative · entry 4 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881 Underlying: Common shares · 23,785 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2003 Filed Nov 18, 2003 21:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 20,777 | $43.86 | $911,279.22 |
DisclosureSEC source: 0001104659-03-026965 · a4.xml · nonDerivative · entry 2 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,821 Read SEC document |
| November 14, 2003 Filed Nov 18, 2003 21:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 23,785 | $34.70 | $825,339.50 |
DisclosureSEC source: 0001104659-03-026965 · a4.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.